Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178029/
http://dx.doi.org/10.1007/s40278-021-96729-4
_version_ 1783703502229340160
collection PubMed
description
format Online
Article
Text
id pubmed-8178029
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-81780292021-06-05 Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines Reactions Weekly Clinical Study Springer International Publishing 2021-06-05 2021 /pmc/articles/PMC8178029/ http://dx.doi.org/10.1007/s40278-021-96729-4 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
title Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
title_full Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
title_fullStr Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
title_full_unstemmed Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
title_short Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
title_sort methotrexate adversely affects immunogenicity to covid-19 mrna vaccines
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178029/
http://dx.doi.org/10.1007/s40278-021-96729-4

Ejemplares similares